Anti-Human CD3 epsilon Recombinant Antibody (TAB-245)

CAT#: TAB-245

Recombinant monoclonal antibody to CD3 epsilon. It is an immunomodulator. It binds to CD3 epsilon.

Gene Expression
Figure 1 IF staining of human cell line JURKAT Figure 2 Lymph node Figure 3 RNA cell line category: Group enriched (JURKAT, MOLT-4)

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • IgG1 - kappa
  • Specificity
  • Tested positive against native human antigen.
  • Species Reactivity
  • Human
  • Applications
  • WB, ELISA, FC, IP, FuncS, IF, Neut
  • Related Disease
  • Atherosclerosis

Product Property

  • Purity
  • >95.0% as determined by analysis by SDS-PAGE.
  • Storage
  • Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.

Applications

  • Application Notes
  • The CD3E antibody has been reported in applications of WB, ELISA, FC, IP, FuncS, IF, Neut.

Target

  • Alternative Names
  • Foralumab;946415-64-1;CD3E;CD3e molecule, epsilon (CD3-TCR complex);CD3e antigen, epsilon polypeptide (TiT3 complex);T-cell surface glycoprotein CD3 epsilon chain;CD3-epsilon;T-cell surface antigen T3/Leu-4 epsilon chain;T-cell antigen receptor complex, e
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for TAB-245. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression Sarah Martinez
15.Oct,23
Great for CD3 Epsilon Studies
The Anti-Human CD3 epsilon Therapeutic Antibody (Foralumab) has been excellent for our CD3 epsilon detection assays. Its specificity and sensitivity are top-notch, providing clear and reliable results. This antibody has significantly improved the accuracy of our experiments and saved us a lot of troubleshooting time.
Breast cancer biomarkers at key points during disease progression Brian Anderson
05.Aug,22
Effective in Immunoassays
We incorporated this antibody into our immunoassays, and it has been a great asset. The specificity for CD3 epsilon is precise, allowing for accurate detection and analysis. The reliable performance has made it an invaluable tool in our lab.
Breast cancer biomarkers at key points during disease progression Megan Thompson
09.Sep,21
Consistent High-Quality Results
This antibody has proven to be consistent and dependable in our assays. The high-quality, reproducible results have significantly improved our experiments, making it a crucial part of our research toolkit. The strong affinity and specificity for CD3 epsilon have been particularly beneficial.

Q&As

  1. Is the anti-Human CD3 epsilon therapeutic antibody Foralumab suitable for use in Western blotting?

    A: Yes, the anti-Human CD3 epsilon therapeutic antibody Foralumab (TAB-245) is suitable for use in Western blotting. It provides specific binding to CD3 epsilon, allowing for reliable detection in Western blot assays.

  2. What are the storage recommendations for the anti-Human CD3 epsilon therapeutic antibody Foralumab?

    A: The recommended storage condition for the anti-Human CD3 epsilon therapeutic antibody Foralumab (TAB-245) is at -20°C or lower. For short-term storage, it can be kept at 2-8°C. To ensure stability, avoid repeated freeze-thaw cycles.

  3. Can the anti-Human CD3 epsilon therapeutic antibody Foralumab be used in immunoprecipitation assays?

    A: Yes, the anti-Human CD3 epsilon therapeutic antibody Foralumab (TAB-245) can be used in immunoprecipitation assays. It provides specific binding to CD3 epsilon, enabling the successful precipitation of the target protein from complex mixtures.

  4. Is the anti-Human CD3 epsilon therapeutic antibody Foralumab effective in ELISA applications?

    A: Yes, the anti-Human CD3 epsilon therapeutic antibody Foralumab (TAB-245) is effective in ELISA applications. It has been validated for use in such assays and provides reliable detection of CD3 epsilon.

  5. What is the optimal dilution for using the anti-Human CD3 epsilon therapeutic antibody Foralumab in immunofluorescence?

    A: The optimal dilution for using the anti-Human CD3 epsilon therapeutic antibody Foralumab (TAB-245) in immunofluorescence is typically 1:100 to 1:500. It is advisable to perform a dilution series to determine the best working concentration for your specific experimental conditions.

View the frequently asked questions answered by Creative Biolabs Support.

Citations

  1. Tran Quang, Christine, et al. "Preclinical efficacy of humanized, non-FcγR-binding anti-CD3 antibodies in T-cell acute lymphoblastic leukemia." Blood, The Journal of the American Society of Hematology 136.11 (2020): 1298-1302. https://doi.org/10.1182/blood.2019003801
    This study investigates the use of humanized, non-Fcg receptor-binding monoclonal antibodies (mAbs) targeting CD3 in the treatment of T-cell acute lymphoblastic leukemia (T-ALL). T-ALL is a highly aggressive malignancy characterized by the proliferation of T-cell precursors. Traditional chemotherapy results in high cure rates in children but less success in adults. This study explores the antileukemic properties of humanized anti-CD3 mAbs, particularly hOKT3g1[Ala/Ala] and foralumab, in xenograft models of T-ALL. These antibodies demonstrated significant antileukemic activity, prolonged host survival, and cooperated with chemotherapy to enhance treatment efficacy, showing minor, manageable adverse effects.
    Creative Biolabs provided essential antibodies for this study, including foralumab (Cat#: BPTG-061) and teplizumab (Cat#: TAB-159) as an alternative source of hOKT3γ1[Ala/Ala]. These antibodies, designed to prevent FcγR binding and reduce immune cell activation, were crucial in demonstrating the potent antileukemic activity in T-cell acute lymphoblastic leukemia (T-ALL) models. Their contribution enabled the researchers to validate the efficacy of non-FcγR-binding anti-CD3 antibodies in reducing leukemia burden and improving survival in xenograft models, thus supporting the potential of these engineered antibodies as a novel therapeutic strategy for T-ALL.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# TAB-245, RRID: AB_3111896)

Copy citation

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biosimilar Overview

Please refer to Foralumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Foralumab.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "CD3E"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
TAB-H28 Anti-Human CD3E Recombinant Antibody (Ertumaxomab) ELISA, FC, IP, FuncS, IF, Neut, ICC IgG2a / G2b
CAT Product Name Application Type
TAB-714 Anti-CD3E Recombinant Antibody (Visilizumab) FuncS, IF, Neut, ELISA, FC, IP, ICC IgG2
TAB-159 Anti-Human CD3E Recombinant Antibody (TAB-159) Neut, ELISA, IF, IP, FuncS, FC, ICC IgG1 - kappa
TAB-H52 Anti-Human CD3E Recombinant Antibody (TAB-H52) FC, IP, ELISA, Neut, FuncS, IF, WB IgG1 - lambda
TAB-420CQ Anti-Human CD3E Recombinant Antibody (Visilizumab) ELISA, IHC, FC, IP, IF, FuncS IgG2, κ
CAT Product Name Application Type
AGTO-G010E Anti-CD3E immunotoxin UCHT1 (scFv)-PE Cytotoxicity assay, Function study
AGTO-G010D Anti-CD3E immunotoxin UCHT1 (scFv)-DT Cytotoxicity assay, Function study
AGTO-G010R Anti-CD3E immunotoxin UCHT1 (scFv)-RTA Cytotoxicity assay, Function study
AGTO-L049E Anti-CD3E immunotoxin (IgG)-PE Cytotoxicity assay, Functional assay
AGTO-L049D Anti-CD3E immunotoxin (IgG)-DT Cytotoxicity assay, Functional assay
CAT Product Name Application Type
TAB-124CL Human Anti-CD3E Recombinant Antibody (TAB-124CL) ELISA Human IgG
CAT Product Name Application Type
AFC-TAB-159 Afuco™ Anti-CD3E ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-159) Neut, ELISA, IF, IP, FuncS, FC ADCC enhanced antibody
AFC-TAB-245 Afuco™ Anti-CD3E ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-245) ELISA, FC, IP, FuncS, IF ADCC enhanced antibody
AFC-TAB-H52 Afuco™ Anti-CD3E ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H52) FC, IP, ELISA, Neut, FuncS, IF ADCC enhanced antibody
AFC-TAB-714 Afuco™ Anti-CD3E ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-714) FuncS, IF, Neut, ELISA, FC, IP ADCC enhanced antibody
AFC-TAB-019 Afuco™ Anti-CD3E ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-019) FC, IP, ELISA, Neut, FuncS, IF ADCC enhanced antibody
CAT Product Name Application Type
VS-0724-XY17 Mouse Anti-CD3E Agonistic Antibody (VS-0724-XY17) FC, IP, ICC, Agonistic assays Mouse IgG1
CAT Product Name Application Type
VS-0724-YC1433 AbPlus™ Anti-CD3E Magnetic Beads (VS-0724-YC1433) IP, Protein Purification
CAT Product Name Application Type
VS-1024-XY94 Mouse Anti-NHP CD3E Recombinant Antibody (clone FN-18) ELISA Mouse IgG1
CAT Product Name Application Type
VS-0325-FY110 Human Anti-CD3E (clone NI-0401) scFv-Fc Chimera ELISA Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0425-YC355 Recombinant Anti-CD3E Vesicular Antibody, EV Displayed (VS-0425-YC355) ELISA, FC, Neut, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare